Opinion

Video

Addressing Payer Coverage Challenges

Key Takeaways

  • Quadruplet regimens face payer coverage challenges, including prior authorization and high patient costs, impacting access to treatment.
  • Providers address these challenges through proactive payer communication and presenting clinical evidence to support regimen efficacy.
SHOW MORE

Panelists discuss how they navigate challenges with payer coverage for quadruplet regimens in multiple myeloma treatment, including strategies they employ to address insurance denials or restrictions, such as providing clinical justification, leveraging recent trial data, and collaborating with financial assistance programs to ensure patients can access optimal therapy despite potential coverage difficulties.

Related Videos
3 experts are featured in this series.
3 experts are featured in this series.
5 experts in this video
5 experts in this video
3d rendering of Bispecific antibodies or BsAbs have two distinct binding domains that can bind to two antigens or two epitopes of the same antigen simultaneously
5 experts in this video
5 experts in this video